CClinicalTrials.gg
TerminatedNCT03672526COMPUFLOUpdated Nov 10, 2022

Monitoring of Injection Pressure During Regional Anesthesia in Pediatric Patient

An interventional study of measure of injection pressure by compuflo in Locoregional Anesthesia, sponsored by University Hospital, Montpellier. Terminated at 1 site in France. Open to participants aged Up to 16 Years. Per ClinicalTrials.gov, last updated 2022-11-10.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Other

Why this study was terminated
decision of the principal investigator
Phase
Not applicable
Study type
Interventional
Enrollment
105
Allocation
Not applicable
Ages
Up to 16 Years
Sex
All
01

Study summary

A low injection pressure is one of the safety elements to check the correct position of the needle during regional anesthesia. Subjective assessment of pressure during manual injection of local anesthetic is most commonly used. In adults, the monitoring of the injection pressure has already been evaluated and makes it possible to objectify the pressure of the injection pressure. This is possible thanks to a device named Compuflo. No study has measured injection pressures during a regional anesthesia in children. The main objective is to control the injection pressures exercised in daily clinical practice during pediatric regional anesthesia with the Compuflo. Regional anesthesia will be proposed and explained during the anesthesia consultation. The procedure will be performed according to the habits of the anesthesiologist in charge of the patient. Only the addition of the Local Anesthetic Injection Pressure monitoring (Compuflo) to the needle changes the usual setup.

Read the detailed description

The purpose of this study is to evaluate the usual practice using Compuflo, allowing the continuous measurement of the injection pressure of the local anesthetic at the needle level. On the day of the surgery, an anesthesiologist "operator" will realize the echo-guided regional anesthesia, qualifying aloud every injection realized (site or compartment of injection, and volume injected). An "observer" anesthesiologist will note the demographic data (age and weight), then the material data (minimum stimulation intensity, type and size of needles and syringes used), and finally he will note the maximum pressure levels reached during the injections performed.

02

Conditions studied

  • Locoregional Anesthesia
03

In context

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Minor patient (0-16 years old) with consent of the major legal representative
  • Affiliated to the social security
  • Informed written consent, notification on the anesthesia sheet

Exclusion criteria

Exclusion Criteria:

  • Patient over 16 years old
  • Patient under tutorship / curatorship
  • Young girl with known or suspected ongoing pregnancy
  • Known allergy to local anesthetics
  • Hemostatic disorder
  • Local infection at the puncture site
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
105 participants (actual)

Study arms

  • Experimental
    device compuflo

    Device: measure of injection pressure by compuflo

Interventions

  • Devicemeasure of injection pressure by compuflo

    injection pressure mesured by Compuflo

06

What researchers measure

Primary outcomes

  1. injection pressure (injection pressure measured by Compuflo)

    injection pressure measured by Compuflo

    Time frame: up to 24 hours (during the ALR)

Secondary outcomes

  1. Pressure values compared to the threshold value used in adults of 15 Psi

    Pressure values compared to the threshold value used in adults of 15 Psi

    Time frame: up to 24 hours (during the ALR)

  2. Pressure values according to the different types of material used

    Pressure values according to the different types of material used

    Time frame: up to 24 hours (during the ALR)

  3. Pressure values in the different infiltrated compartments

    Pressure values in the different infiltrated compartments

    Time frame: up to 24 hours (during the ALR)

  4. Pressure values according to the age of the child

    Pressure values according to the age of the child

    Time frame: up to 24 hours (during the ALR)

  5. Number and ratio of involuntary intra-neural injections

    Number and ratio of involuntary intra-neural injections

    Time frame: up to 24 hours (during the ALR)

  6. Number and ratio of secondary paresthesias

    Number and ratio of secondary paresthesias

    Time frame: up to 24 hours (during the ALR)

07

Study locations

1 site
  • University Hospital of Montpellier
    Montpellier, 34380, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03672526
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Sep 14, 2018
Start date
Oct 8, 2018
Primary completion
Jan 24, 2020
Completion
Jan 24, 2020
Last update
Nov 10, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion